Outcome of relapsed or refractory acute myeloid leukemia treated with intensive salvage chemotherapy in real life in comparison to intermediate dose cytarabine in phase 3 studies

MeSH terms

• Age Factors
• Aged
• Antineoplastic Combined Chemotherapy Protocols / pharmacology
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Clinical Trials, Phase III as Topic
• Cytarabine / pharmacology
• Cytarabine / therapeutic use*
• Dose-Response Relationship, Drug
• Drug Resistance, Neoplasm
• Female
• Humans
• Leukemia, Myeloid, Acute / drug therapy*
• Leukemia, Myeloid, Acute / mortality
• Leukemia, Myeloid, Acute / pathology
• Male
• Middle Aged
• Neoplasm Recurrence, Local / drug therapy*
• Neoplasm Recurrence, Local / mortality
• Neoplasm Recurrence, Local / pathology
• Remission Induction / methods
• Salvage Therapy / methods*
• Survival Analysis
• Time Factors
• Treatment Outcome